High-Dose Versus Standard-Dose Influenza Vaccine in Older Adults With Diabetes

Clinical Editorial

This secondary analysis of a randomized clinical trial examines relative vaccine effectiveness of high-dose vs standard-dose inactivated influenza vaccines against severe respiratory and cardiovascular outcomes according to diabetes status and across diabetes subgroups.

Source Reference

Read the full original publication from the source journal or publisher link below.

Open Original Source More Feed Items

Related by Condition/Drug

Med News TodayRelated by Conditiondiabetesinfluenza

FDA approves Moderna’s mRNA flu vaccine mFLUSIVA for adults 50+: what clinicians should know

Infectious Disease • 23 Aug 2026

SmartLid rapid magnetic-bead extraction improves influenza RT-qPCR sensitivity and subtyping

Infectious Disease • 21 Aug 2026

Air sampling for early detection of respiratory viruses in team spaces during the 2026 FIFA World

Infectious Disease • 18 Aug 2026

High misdiagnosis of bronchiolitis as WHO-classified pneumonia and widespread antibiotic use in Ba

Pediatrics • 14 Aug 2026

Med News TodayRelated by Conditiondiabetesinfluenza

MMR vaccines: separating measles, mumps, rubella shots — myths and facts

Infectious Disease • 12 Aug 2026

Ebola Preparedness: Addressing the Gap in Virus Species Research

Infectious Disease • 10 Aug 2026